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Evidence of a Novel Event during Neuronal
Death: Development of Competence-to-Die
in Response to Cytoplasmic Cytochrome c
prevents apoptosis in a variety of cell types (Salvesen
and Dixit, 1997).
The BCL-2 family of proteins consists of both anti-
apoptotic (e.g., BCL-2, BCL-XL, and BCL-W) and pro-
apoptotic (e.g., BAX, BAK, BAD, BIK, and BID) members.
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The ratio of antiapoptotic to proapoptotic BCL-2 family
members within a cell may determine whether a cell will
die after a death signal (Oltvai et al., 1993; Yang and
Summary Korsmeyer, 1996). Accumulating evidence suggests that
the BCL-2 family proteins form or regulate the formation
Sympathetic neurons undergoing programmed cell of channels on mitochondrial membranes (Schendel et
death after nerve growth factor (NGF) deprivation are al., 1998). The structure of BCL-XL, having two central
shown to exhibit a protein synthesis±dependent, BAX- a helices surrounded by five amphipathic helices, is
dependent loss of cytochrome c from the mitochondria. analogous to that of bacterial toxins such as diphtheria
However, cytoplasmic microinjection of cytochrome c toxin and the colicins (Muchmore et al., 1996). Like the
was insufficient to induce cell death in NGF-maintained bacterial toxins, BCL-XL (as well as BCL-2 and BAX) can
sympathetic neurons. In contrast, microinjection of cyto- insert into synthetic lipid vesicles or planar lipid bilayers
chrome c rapidly induced a caspase-dependent death and form ion-conducting channels (Antonsson et al.,
in NGF-deprived, Bax-deficient or NGF-deprived, cy- 1997; Minn et al., 1997; Schendel et al., 1997; Schle-
cloheximide-treated neurons. Cells needed to be de- singer et al., 1997). Whether these proteins form pores
prived of NGF for 15±20 hr before they acquired com- in mitochondrial membranes in intact cells and what
petence to die with injection of cytochrome c. These signals regulate this activity are not known.
data suggest that NGF deprivation induced the trans- Recent reports have suggested a surprising function
location of cytochrome c and another event, which we for cytochrome c in promoting apoptosis. First, cyto-
chrome c is required for the formation of a complex thatterm as competence-to-die, that was independent of
is sufficient to activate caspases in cell-free extractsmacromolecular synthesis and BAX function. Both
(Liu et al., 1996; Kluck et al., 1997a). In vitro, binding ofthese processes were required for neurons to undergo
Apaf-1, procaspase-9, and cytochrome c, in the pres-apoptosis.
ence of dATP, results in the activation of caspase-9;
activated caspase-9 presumably cleaves and activatesIntroduction
other caspases and promotes subsequent apoptotic
events (Li et al., 1997b). Second, cytochrome c translo-Programmed cell death (PCD) is an evolutionarily con-
cates from the mitochondria to cytosol in cells in several
served and genetically regulated process by which cells
models of apoptosis (Liu et al., 1996; Du et al., 1997;
commit suicide. Cells undergoing PCD exhibit charac- Kharbanda et al., 1997; Kluck et al., 1997a; Srinivasan
teristic morphological changes of apoptosis, including et al., 1998). Third, microinjection of cytochrome c is
cytoplasmic shrinkage, plasma membrane blebbing, sufficient to induce a caspase-dependent cell death in
chromatin condensation, and DNA fragmentation (Kerr some cell lines (Li et al., 1997a).
et al., 1972). PCD occurs extensively during develop- Overexpression of the antiapoptotic BCL-2 or BCL-
ment and may contribute to numerous pathological con- XL protein prevents the translocation of cytochrome c
ditions, including stroke, spinal cord injury, and certain in cells after a death-inducing stimulus (Kharbanda et
neurodegenerative diseases (Choi, 1996; Linnik, 1996; al., 1997; Kluck et al., 1997a; Yang et al., 1997; Duckett
Stefanis et al., 1997). Deficiencies in PCD contribute to et al., 1998; Srinivasan et al., 1998). In contrast, overex-
oncogenesis (Reed, 1997a). pression of the proapoptotic BAX protein promotes the
Genetic and biochemical studies have implicated the translocation of cytochrome c in rat embryo fibroblasts
caspases, Apaf-1, and the BCL-2 family of proteins as (Rosse et al., 1998); addition of BAX also induces the
important regulators of PCD in mammalian cells. These release of cytochrome c from isolated mitochondria
are homologs of the ced-3, ced-4, and ced-9 gene prod- (Jurgensmeier et al., 1998). These observations suggest
ucts, respectively, that are required for regulating PCD a model in which the BCL-2 family proteins regulate the
in Caenorhabditis elegans (Ellis et al., 1991). Caspases, release of cytochrome c from the mitochondria during
PCD, perhaps by their ability to form channels in thewhich are cysteine proteases that cleave after aspartic
mitochondrial membrane. Once released, cytochromeacid residues, appear to be the main executors of apo-
c then binds Apaf-1 and procaspase-9 and, in the pres-ptosis. In cells undergoing PCD, these proteases are
ence of dATP, promotes the activation of caspases andactivated by cleavage of their prodomain; activated cas-
cell death. Thus, several questions about the apoptosis-pases cleave specific cellular proteins and thereby
promoting function of cytochrome c in intact cells re-cause cell death. Inhibition of caspases, either by cellu-
main unanswered. Is the translocation of cytochrome clar or virally encoded inhibitors, or by synthetic peptides,
important in all models of PCD? Is BAX required for the
translocation of cytochrome c? Is cytochrome c translo-




Figure 1. NGF Deprivation Induces Loss of Cytochrome c from the Mitochondria during Sympathetic Neuronal Death
Shown are representative photographs of anti-cytochrome c (cyt c)-immunostained (A±D) or the corresponding bisbenzimide-stained nuclei
(E±H) of sympathetic neurons from either wild-type or Bax-deficient mice. Neurons were maintained in vitro for 5 days in the presence of NGF
and then treated for 72 hr as follows: wild-type neurons maintained in NGF (A and E); wild-type neurons deprived of NGF but in the presence
of 1 mg/ml cycloheximide (CHX) (B and F); Bax-deficient neurons deprived of NGF (C and G); and wild-type neurons deprived of NGF but in
the presence of 50 mM BAF (D and H). Scale bar, 10 mm.
The time course of loss of punctate cytochrome c staining in sympathetic neurons deprived of NGF is shown (I). At various times after NGF
deprivation, sympathetic neuronal cultures from wild-type mice were fixed and immunostained for cytochrome c, and the number of cells
that had lost the punctate staining was determined (circles); these experiments were done in the presence of 50 mM BAF to prevent any cell
loss that otherwise would affect the quantitation. Also shown is the quantitation (for the 72 hr time point) of the lack of cytochrome c
translocation seen in NGF-deprived, cycloheximide-saved sympathetic neurons (triangles) or the NGF-deprived sympathetic neurons from
Bax-deficient mice (squares); data points corresponding to the triangles and squares are overlapping. Results are mean (6 SEM) for at least
three experiments with approximately 100 cells counted for each time point.
In this paper we have examined these questions by BAX-dependent release of cytochrome c. The second
process is a macromolecular synthesis±independent,using the model of sympathetic neuronal death. Sympa-
thetic neurons deprived of nerve growth factor (NGF) BAX-independent development of competence-to-die.
Both processes are required to effect PCD in neuronsinitiate PCD and undergo an apoptotic death within
24±48 hr after NGF removal in culture (Martin et al., 1988; after trophic factor deprivation.
Deckwerth and Johnson, 1993; Edwards and Tolkovsky,
1994; Deshmukh and Johnson, 1997). The NGF depriva- Results
tion±induced sympathetic neuronal death is dependent
on macromolecular synthesis (Martin et al., 1988) and Loss of Cytochrome c from the Mitochondria
Occurs before Caspase Function duringBAX function (Deckwerth et al., 1996) and is prevented
by caspase inhibitors such as boc-aspartyl(OMe)-fluo- Sympathetic Neuronal Death and Requires
Protein Synthesis±Dependent Eventsromethylketone (BAF) (Deshmukh et al., 1996; Troy et
al., 1996; McCarthy et al., 1997). We found that mito- and BAX Activity
Several biochemical and molecular events that occurchondrial localization of cytochrome c was lost during
sympathetic neuronal death, an observation that is con- after NGF deprivation in sympathetic neurons have been
identified and sequentially ordered with respect to thesistent with its translocation to the cytoplasm. This loss
of cytochrome c from the mitochondria was dependent point of BAX or caspase function. The translocation of
cytochrome c from mitochondria is an event that occurson events requiring macromolecular synthesis and BAX
function. However, the cytoplasmic accumulation of cy- prior to the activation of caspases in several nonneu-
ronal models of PCD. We examined whether the translo-tochrome c per se was insufficient to activate caspases
and cause cell death, since cytoplasmic microinjec- cation of cytochrome c also occurred during neuronal
PCD in NGF-deprived sympathetic neurons treated withtion of cytochrome c did not induce cell death in NGF-
maintained sympathetic neurons. In contrast, microin- the caspase inhibitor BAF; BAF addition prevents any
cell death after NGF deprivation that would otherwisejection of cytochrome c induced rapid cell death in
NGF-deprived, Bax-deficient neurons or NGF-deprived, complicate quantitation of results caused by the loss of
neurons from the population. In NGF-maintained sympa-cycloheximide-treated neurons. Further studies indi-
cated that sympathetic neurons needed to be deprived thetic neurons, cytochrome c exhibited a punctate stain-
ing pattern, consistent with its expected mitochondrialof NGF for 15±20 hr before they were able to undergo
cell death after microinjection of cytochrome c. localization (Figure 1A). The pattern of cytochrome c
staining was dramatically altered in NGF-deprived, BAF-Our data provide evidence that two parallel pathways
are operative during NGF deprivation-induced sympa- saved sympathetic neurons from a punctate mitochon-
drial pattern to a diffuse cytoplasmic pattern (Figure 1D).thetic neuronal death. The first process, consistent with
the model, is a macromolecular synthesis±dependent, Analysis of the time course of this phenomenon showed
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very little change in the intracellular localization of cyto-
chrome c within the first 12 hr after NGF deprivation.
However, by 22 hr after NGF deprivation, 50% of neurons
showed diffuse cytochrome c staining, and greater than
90% had lost their mitochondrial cytochrome c staining
by 36 hr after NGF deprivation (Figure 1I).
Sympathetic neurons from Bax-deficient mice do not
undergo apoptosis after NGF deprivation (Deckwerth et
al., 1996). We examined whether BAX was required for
the translocation of cytochrome c subsequent to NGF
deprivation. Sympathetic neurons from Bax-deficient
mice showed no change in cytochrome c localization
and maintained their punctate cytochrome c staining
pattern even after 72 hr of NGF deprivation (Figures 1C
and 1I).
Macromolecular synthesis inhibitors such as cyclo-
Figure 2. NGF Addition Prevents the Loss of Mitochondrial Cyto-heximide prevent sympathetic neurons from undergoing
chrome c during Sympathetic Neuronal DeathPCD after NGF deprivation (Martin et al., 1988). To deter-
Cultures of mouse sympathetic neurons were deprived of NGF inmine whether de novo protein synthesis was required for
the presence of 50 mM caspase inhibitor BAF. At 0, 12, 18, 22, 30,the translocation of cytochrome c during sympathetic
or 34 hr after NGF deprivation, cultures were fixed and immuno-
neuronal death, we examined whether cycloheximide stained with cytochrome c antibodies, and the number of cells that
blocked the neuronal PCD pathway before or after the had lost the punctate staining was quantitated (circles). In parallel
loss of cytochrome c from mitochondria. NGF-deprived, studies, cultures of sympathetic neurons that were deprived of NGF
in the presence of BAF for 18 hr (squares) or 22 hr (triangles) werecycloheximide-saved neurons showed no change in cy-
washed and rescued with readdition of NGF (300 ng/ml). Twelvetochrome c localization and maintained their punctate
hours after NGF readdition, the rescued cells were fixed and immu-cytochrome c staining pattern even after 72 hr of NGF
nostained with cytochrome c antibodies, and the number of cells
deprivation (Figures 1B and 1I). The punctate staining that had lost the punctate staining pattern was determined. Results
pattern of cytochrome c seen in Figure 1 appeared more are mean (6 SEM) for three experiments with approximately 100
condensed in NGF-deprived, Bax-deficient sympathetic cells counted for each time point.
neurons and the NGF-deprived, cycloheximide-saved
neurons as compared to the NGF-maintained neurons.
Sympathetic neurons were deprived of NGF in the pres-This is presumably because NGF deprivation induces
ence of BAF; BAF addition did not prevent cytochromeneuronal atrophy, thereby causing the cytosol to be-
c translocation (as shown in Figure 1) but blocks anycome asymmetrically distributed in the cell.
cell deaths that may otherwise affect the quantitationThus, NGF deprivation induced the loss of cytochrome
(Deshmukh et al., 1996). At 18 or 22 hr after NGF depriva-c from the mitochondria in sympathetic neurons. This
tion, NGF was added back to the cultures and the num-event was dependent on macromolecular synthesis and
ber of cells with diffuse cytochrome c staining 12 hrBAX function but occurred prior to caspase activation,
later was determined. Rescue with readdition of NGFduring sympathetic neuronal death.
completely prevented any further loss of cytochrome
c from the mitochondria of NGF-deprived sympathetic
neurons (Figure 2). The dramatic ability of NGF to abortRescue with NGF Readdition Prevents
Further Release of Cytochrome c the loss of cytochrome c contrasts with the inability
of BAF to prevent cytochrome c translocation. Theseduring Neuronal Death
Sympathetic neurons deprived of NGF for 12 hr can be results indicate that whereas BAF targets caspases,
NGF acts at some proximal step that is required for thefully rescued upon readdition of NGF (Edwards et al.,
1991). Thereafter, the NGF-deprived sympathetic neu- loss of cytochrome c from mitochondria.
rons start becoming irreversibly committed to die; 50%
of sympathetic neurons can no longer be rescued with Microinjection of Cytochrome c Does Not Induce
Cell Death in NGF-Maintained SympatheticNGF readdition by 22 hr after NGF deprivation, and virtu-
ally none can be rescued by 48 hr after NGF deprivation Neurons but Does in NGF-Deprived,
Bax-Deficient Neurons and NGF-Deprived,(Deckwerth and Johnson, 1993). Interestingly, the time
courses with which sympathetic neurons are rescued Cycloheximide-Treated Neurons
Having demonstrated that loss of cytochrome c from thewith NGF readdition or with addition of the caspase
inhibitor BAF are indistinguishable (Deshmukh et al., mitochondria occurred during NGF deprivation-induced
sympathetic neuronal death, we next examined whether1996). Therefore, the target of NGF rescue has been
proposed to be either activated caspases themselves the cytoplasmic accumulation of cytochrome c was suf-
ficient to induce cell death in sympathetic neurons. The(similar to the target of BAF) or some event just proximal
to the activation of caspases (Deshmukh et al., 1996). binding of cytochrome c to Apaf-1 and procaspase-9
(in the presence of dATP) is sufficient to activate cas-As shown above, the translocation of cytochrome c
was an event that immediately preceded caspase acti- pases and cause apoptotic changes in vitro (Li et al.,
1997b). If all components of the caspase-activating ma-vation during sympathetic neuronal death. We examined
whether rescue with NGF readdition blocked PCD be- chinery except cytochrome c are normally present in the
cytosol, then the accumulation of cytochrome c in thefore or after the event of cytochrome c translocation.
Neuron
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Figure 3. Microinjection of Cytochrome c Did
Not Induce Cell Death in NGF-Maintained
Sympathetic Neurons, but It Did in NGF-
Deprived, Bax-Deficient or NGF-Deprived,
Cycloheximide-Treated Neurons
(A) Sympathetic neurons from wild-type (cir-
cles) or Bax-deficient (squares and triangles)
mice were grown in NGF for 4 days, then
maintained for 24±48 hr either in the presence
(circles) or absence (squares and triangles)
of NGF. Cells were then injected with 25 mg/
ml mammalian cytochrome c (filled symbols)
or rhodamine dextran dye alone (open sym-
bols). BAF (50 mM) was added to one set of
NGF-deprived cultures immediately after the
microinjections (triangles). At each time point
after the injections, the number of microin-
jected cells that remained viable was deter-
mined and expressed as a percentage of the
total number of microinjected cells.
(B) Sympathetic neurons from wild-type mice were maintained in NGF for 4 days then treated for 24±48 hr with either NGF (circles), or anti-
NGF plus 1 mg/ml cycloheximide (CHX; squares, triangles, diamonds). Cells were microinjected with 25 mg/ml mammalian cytochrome c, and
the number of viable cells remaining was determined as described in (A). Some NGF-deprived, cycloheximide-treated cultures were treated
with 50 mM BAF immediately after the microinjections (triangles), or with 300 ng/ml NGF either immediately after the microinjections (filled
diamonds) or 30 min prior to the microinjections (open diamonds).
Results are mean (6 SEM) for three experiments with approximately 100 cells counted for each time point.
cytoplasm should be sufficient to activate caspases and dependent, since PCD was blocked by the caspase in-
hibitor, BAF (Figure 3A; filled triangles).cause cell death in sympathetic neurons. Therefore, we
tested whether cytoplasmic microinjection of cytochrome Like sympathetic neurons from Bax-deficient mice,
cycloheximide-treated neurons can also be deprived ofc induced cell death in NGF-maintained sympathetic
neurons. Microinjection of mammalian cytochrome c (25 NGF and be kept alive because these cells are arrested
at a macromolecular synthesis±dependent step duringmg/ml) did not induce cell death in NGF-maintained
sympathetic neurons (Figure 3A; filled circles). The con- neuronal death (Martin et al., 1988). We examined whether
microinjection of cytochrome c induced cell death incentration of cytochrome c injected in this experiment
is unlikely to be limiting because a 5-fold lower concen- cycloheximide-treated sympathetic neurons that were
deprived of NGF for 24±48 hr. Microinjection of cyto-tration of cytochrome c was sufficient to induce rapid
cell death in these neurons under other conditions (see chrome c (25 mg/ml) rapidly induced cell death in the
NGF-deprived, cycloheximide-treated neurons with 80%below).
The above data show that cytochrome c was insuffi- neurons dying within 6 hr after cytochrome c microin-
jection (Figure 3B; filled squares); dying cells showedcient to induce cell death in NGF-maintained sympa-
thetic neurons. However, as shown in Figure 1I, cyto- chromatin condensation typically seen during apoptosis
(data not shown). The cytochrome c±induced death ofchrome c release that presumably leads to caspase
activation is observed in neurons that had been deprived NGF-deprived, cycloheximide-treated neurons was also
dependent on caspase activation, since PCD was pre-of NGF for at least 12 hr. Therefore, we examined
whether sympathetic neurons needed to be deprived of vented by the caspase inhibitor, BAF (Figure 3B; filled
triangles). As described above, microinjection of cyto-NGF before microinjection of cytochrome c was able to
kill neurons. We used two situations in which cells could chrome c did not induce cell death in NGF-maintained
sympathetic neurons (Figure 3B; filled circles). Also, mi-be deprived of NGF yet remained alive: Bax-deficient or
cycloheximide-treated sympathetic neurons. Bax-defi- croinjection of dye alone did not induce cell death in
NGF-deprived, cycloheximide-treated neurons (data notcient sympathetic neurons do not undergo apoptosis
when deprived of NGF because the cell death program shown). Furthermore, microinjection of cytochrome c
did not induce cell death in NGF-maintained sympa-is arrested at a BAX-dependent point prior to cyto-
chrome c release (see Figure 1). These neurons remain thetic neurons treated with cycloheximide, indicating
that cycloheximide treatment alone did not make sym-viable in this NGF-deprived state for several weeks in
culture (Deckwerth et al., 1996). Sympathetic neurons pathetic neurons sensitive to microinjection of cyto-
chrome c (Figure 4A; filled triangles).from Bax-deficient mice were deprived of NGF for 24±48
hr and then microinjected with cytochrome c. Microin- Thus, the cytoplasmic accumulation of cytochrome c
was not sufficient to induce cell death in NGF-main-jection of cytochrome c (25 mg/ml) rapidly induced cell
death in NGF-deprived, Bax-deficient neurons (Figure tained sympathetic neurons. However, microinjection
of cytochrome c induced a rapid, caspase-dependent3A; filled squares). Greater than 40% of cells were dead
by 3 hr after cytochrome c injection, and almost 80% death in cells that were maintained in the context of NGF
deprivation, such as the NGF-deprived, Bax-deficientwere dead by 6 hr after the injections. Microinjection of
dye alone did not induce cell death in these neurons neurons or the NGF-deprived, cycloheximide-treated
neurons.(Figure 3A; open circles and open squares). Cell death
induced by microinjection of cytochrome c was caspase Previous reports indicate that yeast (Saccharomyces
Parallel Processes Are Required for Neuronal Death
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Figure 4. Cycloheximide Treatment Alone Is
Not Sufficient to Make Sympathetic Neurons
Susceptible to Microinjection of Mammalian
Cytochrome c
(A) Sympathetic neurons from wild-type mice
were maintained in NGF for 4 days then
treated for 24±48 hr with either NGF (cir-
cles), NGF plus 1 mg/ml cycloheximide (trian-
gles), or anti-NGF plus 1 mg/ml cycloheximide
(squares). Cells were microinjected with 25
mg/ml mammalian cytochrome c, and the num-
ber of viable cells remaining was determined
as described in the legend to Figure 3A.
(B) Specificity of cytochrome c in inducing
sympathetic neuronal death. Sympathetic
neurons from wild-type mice were deprived
of NGF in the presence of cycloheximide for
24±48 hr and then injected with 25 mg/ml of
either mammalian cytochrome c (squares),
partially acetylated mammalian cytochrome c (triangles), or yeast cytochrome c (diamonds). Cell survival was determined as described in the
legend to Figure 3A.
Results are mean (6 SEM) for three experiments with approximately 100 cells counted for each time point.
cerevisiae) cytochrome c or partially acetylated mam- NGF might induce the phosphorylation of some proteins
and directly prevent caspase activation. If this hypothe-malian cytochrome c does not substitute for mammalian
sis were correct, addition of NGF to the NGF-deprived,cytochrome c in activating caspases in cell-free extracts
cycloheximide-treated neurons at the time of cyto-(Ellerby et al., 1997; Kluck et al., 1997b). Consistent with
chrome c microinjection should block cell death inducedthese in vitro results, we found that microinjection of
by cytochrome c in those neurons. To examine this pos-yeast cytochrome c or partially acetylated mammalian
sibility, NGF-deprived, cycloheximide-treated neuronscytochrome c did not induce cell death in NGF-deprived,
were microinjected with 25 mg/ml cytochrome c. Im-cycloheximide-treated sympathetic neurons (Figure 4B).
mediately after the microinjections, the cultures were
washed extensively and NGF was added to the medium.Cytochrome c±Induced Death Is Dose Dependent
However, NGF addition did not prevent cell death in-The experiments described above demonstrate that mi-
duced by microinjection of cytochrome c (Figure 3B;croinjection of 25 mg/ml cytochrome c induced cell
filled diamonds). Similarly, NGF addition even 30 mindeath in NGF-deprived sympathetic neurons. This con-
prior to microinjection of cytochrome c, to allow suffi-centration of cytochrome c was chosen for the initial
cient time for any NGF signaling mechanisms to becomeexperiments because similar concentrations of cyto-
established (Halegoua and Patrick, 1980), had no effectchrome c are sufficient to induce cell death in human
on cytochrome c±induced cell death (Figure 3B).embryonic kidney 293 cells (Li et al., 1997a). To de-
Although these results show that NGF was unable totermine the minimum concentration of cytochrome c
prevent cell death after microinjection of cytochrome c,needed to induce cell death in sympathetic neurons, we
it remained possible that the concentration of cyto-examined the dose response for cytochrome c. Sympa-
chrome c microinjected into these neurons (25 mg/ml)thetic neurons that were deprived of NGF for 24 hr in
was much greater than that required to activate cas-the presence of cycloheximide were microinjected with
pases. The high concentration of cytochrome c mayincreasing concentrations of cytochrome c (0±25 mg/
have overwhelmed any ability of NGF to block cell deathml), and the extent of cell death was determined at
physiologically after cytochrome c microinjection. As
various times after microinjection. Microinjection of cy-
shown above, 2.5 mg/ml and 5 mg/ml cytochrome c
tochrome c showed an exponential dose response be- represent the minimum concentrations of cytochrome
tween 1 and 5 mg/ml with the maximum death-inducing c needed to induce cell death in sympathetic neurons
response observed at 5 mg/ml cytochrome c (Figures (Figures 5A and 5B). We examined whether NGF addition
5A and 5B). Microinjection of 10 mg/ml or 25 mg/ml could prevent cell death induced by microinjection of
cytochrome c induced cell death with a time course that these threshold concentrations of cytochrome c. How-
was identical to that observed with microinjection of 5 ever, addition of NGF (30 min prior to injection) to NGF-
mg/ml of cytochrome c. deprived, cycloheximide-treated cultures microinjected
with either 2.5 mg/ml or 5 mg/ml cytochrome c still had
Cytochrome c±Induced Sympathetic Neuronal no effect on cell death induced by cytochrome c in these
Death Is Prevented with the Caspase Inhibitor neurons (Figure 5C).
BAF but Not by Addition of NGF The inability of NGF to prevent cell death after microin-
One reason why microinjection of cytochrome c may jection of cytochrome c contrasts with the ability of the
not be able to induce cell death in NGF-maintained sym- caspase inhibitor BAF to block cell death when added
pathetic neurons is that NGF exerts a block on the neu- immediately after the microinjection (as shown in Figure
ronal PCD pathway after the translocation of cyto- 3). These results suggest that BAF, but not NGF, can
chrome c. For example, in addition to blocking the prevent neuronal death once cytochrome c has translo-
cated to the cytoplasm.translocation of cytochrome c (as shown in Figure 2),
Neuron
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Figure 5. Killing by Cytochrome c Is Dose Dependent and Is Not Blocked by Acute Exposure to NGF
(A) Microinjection of cytochrome c induces sympathetic neuronal death in a dose-dependent manner. Sympathetic neurons were deprived
of NGF in the presence of cycloheximide for 24±48 hr, then microinjected with rhodamine dextran dye alone (open circles) or 1 mg/ml
(diamonds), 2.5 mg/ml (down triangles), 5 mg/ml (up triangles), 10 mg/ml (squares), or 25 mg/ml (closed circles) of mammalian cytochrome
c. Neuronal survival at 0, 3, 8, or 24 hr after microinjection of cytochrome c was determined.
(B) Survival of sympathetic neurons at 8 hr postinjection (data from [A]) was plotted as a function of cytochrome c concentration.
(C) Addition of NGF does not block the sympathetic neuronal death induced by microinjection of cytochrome c. Sympathetic neurons were
deprived of NGF in the presence of cycloheximide for 24±48 hr, then microinjected with 5 mg/ml (circles) or 2.5 mg/ml (squares) of mammalian
cytochrome c. To a subset of these cultures, 300 ng/ml NGF was added 30 min prior to the microinjections (open symbols). Neuronal survival
after the microinjections was determined as described above in Figure 3A.
Results are mean (6 SEM) for three experiments with approximately 100 cells counted for each time point.
NGF Deprivation Is Required for Sympathetic To determine how long sympathetic neurons must be
deprived of NGF before they developed competence-Neurons to Develop Competence-to-Die
with Microinjection of Cytochrome c to-die with microinjection of cytochrome c, sympathetic
neurons were deprived of NGF in the presence of cyclo-The results described above indicate that microinjection
of cytochrome c was insufficient to induce cell death heximide. At various times after NGF deprivation, neu-
rons were microinjected with 5 mg/ml cytochrome c,in NGF-maintained sympathetic neurons, whereas similar
microinjections rapidly induced cell death in sympa- and the extent of cell death was determined 3 hr after
the injections. The 3 hr time point was chosen becausethetic neurons that were maintained in the context of
NGF deprivation such as the NGF-deprived, Bax-defi- it was the minimum time period needed to detect sub-
stantial cell death. Sympathetic neurons became com-cient neurons or NGF-deprived, cycloheximide-treated
neurons. Our results argue against the possibility that petent-to-die with microinjection of cytochrome c by 24
hr after NGF deprivation; NGF deprivation for longerNGF-maintained neurons are resistant to cell death in-
duced by microinjection of cytochrome c, because NGF periods did not result in any further increase in cell death
(Figure 6B). Half of the sympathetic neurons developedblocks neuronal PCD after the cytoplasmic accumula-
tion of cytochrome c. Therefore, we considered the pos- competence-to-die by 16±18 hr after NGF deprivation.
These results indicate that NGF deprivation was re-sibility that NGF deprivation per se induces other events
that are required for sympathetic neurons to become quired to induce a state of competence in sympathetic
neurons that allows them to undergo cell death withsensitive to cytochrome c±induced death.
We examined whether cytochrome c could induce cell microinjection of cytochrome c. Since sympathetic neu-
rons develop this competence in the presence of cyclo-death in sympathetic neurons if these neurons were
deprived of NGF immediately after microinjection or if heximide (NGF-deprived, cycloheximide-treated neurons)
or in the absence of BAX (NGF-deprived, Bax-deficientsympathetic neurons need to be deprived of NGF for a
period of time before they developed competence-to- neurons), the development of competence does not re-
quire protein synthesis or BAX function.die in response to microinjection of cytochrome c. Mi-
croinjection of cytochrome c did not induce cell death
in sympathetic neurons that were deprived of NGF im-
mediately after the injection (Figure 6A; filled triangles). Discussion
In contrast, cytochrome c induced rapid cell death in
sympathetic neurons that were deprived of NGF for 24 Loss of Cytochrome c from the Mitochondria
during Sympathetic Neuronal Deathhr prior to the injection (described in previous sections
and Figure 6A; filled squares). NGF was withdrawn in In this paper, we examined how caspases become acti-
vated during neuronal death. We asked whether mito-the presence of cycloheximide to prevent any cell death
that would be caused by NGF deprivation alone, as chondrial release of cytochrome c, which occurs in
several nonneuronal models of apoptosis, also occursdescribed previously.
Parallel Processes Are Required for Neuronal Death
701
Figure 6. NGF Deprivation Is Needed for
Sympathetic Neurons to Develop Compe-
tence-to-Die after Microinjection of Cyto-
chrome c
(A) Sympathetic neurons were grown in NGF
for 4 days and then were maintained in the
presence of NGF for 2 days (circles and trian-
gles) or deprived of NGF in the presence of
cycloheximide for 24 hr (squares). Neurons
were then microinjected with 5 mg/ml mam-
malian cytochrome c, and cell survival was
determined as described above in Figure 3A.
A subset of NGF-maintained cultures was de-
prived of NGF in the presence of cyclohexi-
mide immediately after the microinjections
(triangles).
(B) Sympathetic neurons were maintained in
NGF for 4 days and then deprived of NGF in
the presence of cycloheximide. At 0, 3, 6, 12,
18, 24, or 36 hr after NGF deprivation, neurons were microinjected with 5 mg/ml mammalian cytochrome c, and the number of viable neurons
remaining at 3 hr after the microinjection of cytochrome c was determined.
Results are mean (6 SEM) for three experiments with approximately 100 cells counted for each time point.
during sympathetic neuronal death. We found that cyto- await the generation of conditional null mutants of cyto-
chrome c that eliminate the death-promoting activitychrome c is lost from the mitochondria after NGF depri-
vation during sympathetic neuronal death. Consistent but maintain its essential function in oxidative phosphor-
ylation.with observations in other models of PCD, loss of cyto-
chrome c from the mitochondria occurs prior to caspase Inhibitors of macromolecular synthesis, such as cyclo-
heximide, prevent the NGF deprivation-induced apopto-function during neuronal death (Figure 1).
Several recent reports suggest that the BCL-2 family sis of sympathetic neurons (Martin et al., 1988). We
found that addition of cycloheximide to NGF-deprivedof proteins, BAX in particular, regulates the release of
cytochrome c during apoptosis (Reed, 1997b). Sympa- sympathetic neurons blocked apoptosis prior to the loss
thetic neurons are completely dependent on BAX for of cytochrome c from the mitochondria (Figure 1). Thus,
undergoing apoptosis (Deckwerth et al., 1996). There- a macromolecular synthesis±dependent event(s) was
fore, we tested whether BAX was required for the release required for the release of cytochrome c from mitochon-
of cytochrome c during apoptosis. Our results show that dria after NGF deprivation. Taken together, these results
NGF-deprived sympathetic neurons from Bax-deficient demonstrate that NGF deprivation induced a macromo-
mice maintained their punctate staining pattern of cyto- lecular synthesis±dependent, BAX-dependent loss of cy-
chrome c, indicating that BAX was required for the loss tochrome c from the mitochondria during neuronal PCD.
of cytochrome c from mitochondria during neuronal
apoptosis (Figure 1). Whether the release of cytochrome
NGF Readdition Rescues Sympathetic Neuronsc occurred as a consequence of the insertion of BAX
up to the Point of Cytochrome c Releaseinto the mitochondria of sympathetic neurons and for-
during PCDmation of ion-selective channels is not known.
PCD induced by NGF deprivation in sympathetic neu-Our results support the hypothesis that the BAX-
rons can be aborted by the readdition of NGF even if NGFdependent release of cytochrome c is important in
is added very late during the death process (Edwards etmediating caspase activation during trophic factor
al., 1991; Deckwerth and Johnson, 1993). Although NGFdeprivation±induced neuronal death. The inability of
signals postranslationally to block neuronal PCD, thecytochrome c to translocate after NGF deprivation in
mechanism by which NGF readdition acts to preventBax-deficient sympathetic neurons correlated with the
neuronal apoptosis is not known. Previous studies couldinability of these neurons to undergo NGF depriva-
not resolve any temporal difference between the timetion±induced apoptosis. Furthermore, microinjection of
course of rescue with addition of NGF or BAF. Hence,cytochrome c into the cytoplasm of NGF-deprived,
the target of NGF rescue had been proposed to be eitherBax-deficient sympathetic neurons, which bypasses the
activated caspases or some event immediately preced-cytochrome c translocation defect observed in these
ing caspase activation (Deshmukh et al., 1996).neurons, allowed these cells to undergo a rapid, cas-
In this study, we have identified important differencespase-dependent cell death (Figure 3). Since microinjec-
between the mechanisms of NGF and BAF rescue. Wetion of cytochrome c alone was sufficient to complement
find that NGF readdition prevented the loss of cyto-the apoptotic defect in the NGF-deprived, Bax-deficient
chrome c from mitochondria during sympathetic neu-sympathetic neurons, the essential function of BAX in
ronal death (Figure 2), whereas BAF addition did notneuronal apoptosis must likely be to mediate the translo-
(Figures 1 and 2). Furthermore, our results indicate thatcation of cytochrome c. Therefore, these results imply
NGF was unable to prevent neuronal apoptosis oncethat the translocation of cytochrome c is important for
cytochrome c accumulated in the cytoplasm, since NGFmediating NGF deprivation±induced sympathetic neu-
readdition did not prevent cell death induced by microin-ronal death. Experiments that directly examine the re-
quirement for cytochrome c in neuronal apoptosis must jection of cytochrome c, whereas BAF did (Figures 3B
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and 5C). These results are consistent with a model in make these neurons susceptible to cytochrome c±induced
which NGF can block the neuronal PCD pathway only death (Figure 4A and data not shown). Third, the ab-
until the point of cytochrome c release. This is further sence of NGF, and not cycloheximide treatment or Bax
supported by the observation that the time course of deficiency per se, induced susceptibility to cytochrome
loss of cytochrome c (Figure 1I) is identical to the time c±induced death. As mentioned above, microinjection
course with which NGF loses its ability to prevent neu- of cytochrome c did not induce cell death in NGF-main-
ronal death (Deckwerth and Johnson, 1993). tained sympathetic neurons treated with cycloheximide;
similarly, microinjection of cytochrome c did not induce
Sympathetic Neurons Must Develop Competence cell death in Bax-deficient sympathetic neurons main-
before They Become Susceptible to tained in NGF (data not shown).
Cytochrome c±Induced Cell Death We considered the possibility that one reason NGF
Although several reports have recently demonstrated deprivation is needed for sympathetic neurons to be-
that cytochrome c translocates from the mitochondria come susceptible to microinjection of cytochrome c was
to the cytosol during PCD, few have addressed whether that NGF may signal posttranslationally to block the
the cytoplasmic accumulation of cytochrome c is suffi- cytochrome c±induced activation of caspases and, thus,
cient to activate caspases and cause apoptosis in cells block cell death. Our data argue against this possibility.
(Liu et al., 1996; Du et al., 1997; Kharbanda et al., 1997; Addition of NGF to NGF-deprived, cycloheximide-treated
Kluck et al., 1997a; Li et al., 1997a; Srinivasan et al., neurons did not block the cell death induced by microin-
1998). Our results show that microinjection of cyto- jection of cytochrome c even when NGF was added 30
chrome c was not sufficient to activate cell death in min prior to the injections to allow time for any posttrans-
sympathetic neurons maintained in NGF. However, mi- lational modifications to occur (Figure 5C). Conversely,
croinjection of cytochrome c induced rapid cell death removal of NGF from NGF-maintained sympathetic neu-
in sympathetic neurons that were maintained in the ab- rons a few hours prior to the injections did not make
sence of NGF, such as the Bax-deficient and cyclohexi- these neurons susceptible to cytochrome c±induced cell
mide-treated sympathetic neurons (Figure 3). Death in- death (Figure 6).
duced by microinjection of cytochrome c in sympathetic These results indicate that sympathetic neurons
neurons occurred as a consequence of caspase activa- needed to be deprived of NGF for a period before the
tion, since PCD was completely inhibited by the caspase neurons developed competence-to-die with microinjec-
inhibitor BAF (Figures 3A and 3B). This result argues
tion of cytochrome c. Half the neurons developed com-
against the possibility that cytochrome c was merely
petence-to-die by 16±18 hr after NGF deprivation, and
toxic to the cells. Furthermore, the inability of yeast
all neurons did so by 24 hr after NGF deprivation (Fig-cytochrome c or partially acetylated mammalian cyto-
ure 6). Thus, NGF deprivation induced a state of com-chrome c to induce cell death in sympathetic neurons
petence in sympathetic neurons that allowed theseprovides additional evidence for the specificity of the
neurons to initiate a caspase-dependent death aftercell death induced by cytochrome c in these experi-
microinjection of cytochrome c. Furthermore, the devel-ments (Figure 4B).
opment of competence required neither macromolecu-Previous reports suggest that cytochrome c±induced
lar synthesis nor BAX function, since the NGF-deprived,death requires the expression of caspase-3 (Li et al.,
Bax-deficient and NGF-deprived, cycloheximide-treated1997a). MCF7F cells lack caspase-3 and, as a conse-
sympathetic neurons developed competence-to-die withquence, are resistant to cytochrome c±induced cell
microinjection of cytochrome c.death. However, unlike MCF7F cells, sympathetic neu-
Based on these results, we propose that NGF depriva-rons express caspase-3 (Deshmukh et al., 1996). Hence,
tion±induced cell death in sympathetic neurons requiresthe inability of cytochrome c to induce cell death in
the cooperation of two events (summarized in FigureNGF-maintained sympathetic neurons is not readily ex-
7): first, a macromolecular synthesis±dependent, BAX-plained by any obvious deficiency of caspase-3 in these
dependent release of cytochrome c from the mitochon-neurons.
dria; second, the development of competence that doesSo why does cytochrome c induce sympathetic neu-
not require macromolecular synthesis or BAX function.ronal death in the absence, but not the presence, of
Neither event by itself is sufficient to induce cell death.NGF? Our data indicate that NGF deprivation is needed
Since the time courses for the loss of cytochrome cfor sympathetic neurons to develop competence-to-die
(Figure 1I) and the development of competence (Figurewith microinjection of cytochrome c. First, microinjec-
6B) are similar, these two events most likely occur simul-tion of cytochrome c induced rapid cell death in NGF-
taneously, albeit independently, after NGF deprivationdeprived, Bax-deficient neurons and NGF-deprived,
in sympathetic neurons.cycloheximide-treated sympathetic neurons, whereas
The molecular basis for the development of compe-even a 5-fold greater concentration of cytochrome c did
tence is not known. One hypothesis is that the develop-not induce any cell death in NGF-maintained sympa-
ment of competence may involve either the sequesteringthetic neurons (Figures 3, 4, and 5). Second, the suscep-
or degradation of an antiapoptotic factor that blocks celltibility of NGF-deprived, Bax-deficient or NGF-deprived,
death after the translocation of cytochrome c. Recentcycloheximide-treated neurons to cytochrome c±induced
reports indicate that antiapoptotic proteins such asdeath was not caused solely by their decreased meta-
BCL-XL and the inhibitor-of-apoptosis proteins (IAPs)bolic rates (compared to the NGF-maintained neurons).
prevent apoptosis by acting at a point distal to the re-Decreasing the metabolic rate in NGF-maintained sym-
lease of cytochrome c (Roy et al., 1997; Clem et al.,pathetic neurons by addition of cycloheximide, depriva-
tion of glucose, or both treatments combined did not 1998; Deveraux et al., 1998; Duckett et al., 1998; Hu et al.,
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Figure 7. Sympathetic Neuronal Death In-
duced by NGF Deprivation
Sequence of events occurring after NGF dep-
rivation in sympathetic neurons undergoing
apoptosis. ROS, reactive oxygen species;
SOD, superoxide dismutase; CHX, cyclohexi-
mide; cyt c, cytochrome c. Overexpression
of SOD presumably inhibits sympathetic neu-
ronal apoptosis by inhibiting the increase in
ROS. The event inhibited by CHX is unknown.
One possibility is that CHX may inhibit the
expression of c-jun or a gene product whose
expression is regulated by c-jun. The devel-
opment of competence is shown as 1 or 2
to denote either the accumulation or degra-
dation of a factor. The translocation of BAX
to mitochondria is inferred from data in non-
neuronal cell lines undergoing apoptosis.
Two possible sites of BCL-2 action are sug-
gested: inhibition of BAX translocation, or in-
hibition of the release of cytochrome c subse-
quent to BAX translocation. Question marks
indicate uncertainty between these possibil-
ities.
1998; Pan et al., 1998). Alternatively, the development of occur during normal mitochondrial turnover and bio-
genesis in neurons. Neurons, being irreplaceable, may,competence may involve the accumulation of a cofactor
that is required for caspase activation. One such candi- therefore, have evolved a mechanism that requires both
cytochrome c release and the development of compe-date is dATP. Addition of 1 mM dATP (or higher amounts
of ATP) is required for cytochrome c to activate cas- tence to prevent ªaccidentalº activation of caspases
in such situations. In contrast, physiological apoptoticpases in vitro (Liu et al., 1996). Whether dATP is the
required cofactor needed for caspase activation in vivo stimuli, such as trophic factor deprivation, would induce
both cytochrome c release and the development of com-remains unclear. We found that microinjection of dATP
(25 mM dATP pipette concentration corresponding to an petence, thereby ensuring the physiologically appro-
priate activation of caspases and cell death.approximate final intracellular concentration of 0.25±2.5
mM dATP after injection) and cytochrome c together
still did not induce cell death in NGF-maintained sympa- Experimental Procedures
thetic neurons (data not shown). However, a different, as
Reagentsyet unknown, cofactor may be required for cytochrome c
Bovine cytochrome c, partially acetylated horse cytochrome c, andto activate caspases in sympathetic neurons.
yeast cytochrome c were purchased from Sigma (St. Louis, MO).
All other reagents were also purchased from Sigma unless otherwise
Why Might Neurons Require the Development stated. Collagenase and trypsin were purchased from Worthington
of Competence before Cytochrome c Biochemical (Freehold, NJ). Caspase inhibitor boc-aspartyl(OMe)-
fluoromethylketone (BAF) was purchased from Enzyme SystemsCan Induce Cell Death?
Products (Livermore, CA). Untimed-pregnant ICR mice were pur-The observation that sympathetic neurons must be de-
chased from Harlan Sprague Dawley (Indianapolis, IN). Breedingprived of NGF before they developed competence-to-
and genotyping of Bax-deficient mice has been described previouslydie with microinjection of cytochrome c contrasts with
(Knudson et al., 1995; Deckwerth et al., 1996).
the recent report that microinjection of cytochrome c is
sufficient to activate a caspase-dependent death in Sympathetic Neuronal Cultures
HeLa and 293 cells (Li et al., 1997a). Whether this differ- Primary cultures of sympathetic neurons from the superior cervical
ence in susceptibility to cytochrome c microinjection ganglion (SCG) neurons were prepared from postnatal day-1 (P1)
mice essentially as described previously for rats (Johnson and Ar-is reflective of a difference between a mitotic and a
giro, 1983; Deshmukh et al., 1996). Briefly, the dissected gangliapostmitotic cell is unclear. We note, however, that the
were treated with collagenase (1 mg/ml), then trypsin (2.5 mg/ml) fordecision to undergo apoptosis needs to be tightly regu-
30 min each at 378C. The ganglia were triturated, and the dissociated
lated particularly in postmitotic cells, such as neurons, cells were plated on collagen-coated dishes in NGF-containing
since these cells cannot be easily replaced. In contrast, medum (AM50). This medium contained Eagle's minimum essential
the death of mitotic cells need not be catastrophic for medium with Earle's salts (Life Technologies, Inc., Gaithersburg,
MD) with the addition of 50 ng/ml 2.5 S NGF, 10% fetal calf serum,the organism, since these cells can be replaced by nor-
2 mM glutamine, 100 mg/ml penicillin, and 100 mg/ml streptomycin;mal cell proliferation. Several situations in the life span
20 mM fluorodeoxyuridine, 20 mM uridine, and 3.3 mg/ml aphidicolinof neurons may result in accidental or physiological re-
were also included to reduce the number of nonneuronal cells.
lease of cytochrome c into the cytoplasm. For example,
extrinsic or intrinsic perturbations may transiently depo-
Culture Conditions
larize mitochondria and result in some release of cyto- Sympathetic neuronal cultures were grown in NGF-containing me-
chrome c (Scarlett and Murphy, 1997; Yang and Corto- dium (AM50) for 4±5 days and then either maintained in AM50 or
treated with various conditions as follows. For NGF deprivation,passi, 1998). Alternatively, cytochrome c release might
Neuron
704
cultures were rinsed twice with medium lacking NGF (AM0: AM50 injected was determined by counting the number of rhodamine-
positive cells that had intact, phase-bright cell bodies. Cultures weremedium without NGF), followed by addition of AM0 containing goat
anti-NGF neutralizing antibody (Ruit et al., 1990). For NGF depriva- then switched to the appropriate medium and, at various times after
injections, the number of viable, injected neurons remaining wastion in the presence of cycloheximide or the caspase inhibitor, 1
mg/ml cycloheximide or 50 mM BAF was added, respectively, to the determined by using the same counting criterion. To assess whether
the cytochrome c±injected cells exhibited condensed chromatin,anti-NGF-containing medium. For experiments in which NGF was
readded to cultures after NGF deprivation, cultures were rinsed cells were fixed with 4% paraformaldehyde (in PBS) 3 hr after cyto-
chrome c injection and stained with the nuclear dye bisbenzimide.three times with the AM50 medium and then incubated in AM50
medium containing 300 ng/ml NGF (instead of 50 ng/ml); the greater An estimation of the amount of cytochrome c injected in these
experiments is calculated as follows. SCG cell volume is calculatedconcentration of NGF was added to ensure complete neutralization
of the anti-NGF antibodies that may have remained from the previ- to be approximately 4 fl based on the average cell diameter of 20
mm. We estimate that the amount injected into cells correspondsous treatments.
to 1%±10% of the total cell volume. Based on these calculations,
injection of 25 mg/ml and 5 mg/ml pipette concentrations of cyto-Immunohistochemistry
chrome c are likely to represent final intracellular concentrations ofNeuronal cultures were immunostained as previously described
0.25±2.5 mg/ml (1±10 pg injected) and 0.05±0.5 mg/ml (0.2±2 pg(Easton et al., 1997). Briefly, sympathetic neurons (1500±3000 cells)
injected) of cytochrome c, respectively. Likewise, injection of 25were grown on collagen-coated, 2-well glass chamber slides (Nalge
mM dATP is likely to represent a final intracellular concentration ofNunc Int., Naperville, IL) in the appropriate medium. Cultures were
0.25±2.5 mM dATP in cells.washed once with phosphate-buffered saline (PBS) and then fixed
with freshly made 4% paraformaldehyde in PBS for 30 min at 48C.
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